About SSI Diagnostica
SSI Diagnostica is a Healthcare company based in Hillerød (Denmark) founded in 2016, and was acquired by Adelis Equity Partners in March 2016. Diagnostic and quality control testing kits are manufactured. SSI Diagnostica has completed 2 acquisitions, including CTK Biotech and TECHLAB. Its chief executive, as recorded, is Soren Skjold Mogensen. Its focus areas include Traditional Diagnostics.
Company details
SSI Diagnostica was founded in 2016 and is based in Hillerod, Denmark. Operations focus on the production of diagnostic kits and quality control testing solutions within the healthcare sector. These products support laboratory and clinical testing needs. The company is led by CEO Soren Skjold Mogensen, with activities centered on European markets.
- Headquarters Hillerød, Denmark
- Stage Acquired
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Email••••••••
- Phone•••• ••••
- Website ssidiagnostica.com
- Social LinkedIn Facebook
- Acquired by Adelis Equity Partners (Mar 2016)
- Annual Revenue$44.77 M (USD)-40as on Dec 31, 2022
- Net Profit$16.39 M (USD)-56as on Dec 31, 2022
- Investors
- Investments & AcquisitionsCTK Biotech
& 1 more
- Acquired byAdelis Equity Partners
(Mar 2016)
Investors in SSI Diagnostica
SSI Diagnostica has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Adelis Equity.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Adelis Equity is engaged in growing Nordic businesses through partnerships. | adelisequity.com | Stockholm, Sweden |
Investor details for SSI Diagnostica
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of SSI Diagnostica
3 people are tracked at SSI Diagnostica (2 in leadership, 1 in team).
| Name | Role | Group |
|---|---|---|
Soren Skjold Mogensen | CEO | Leadership |
Lars Henrik Vejrup Hansen | Group CFO | Leadership |
Rasmus Aagaard Jensen | Financial Controller | Team |
Complete people profiles for SSI Diagnostica
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by SSI Diagnostica
SSI Diagnostica has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include CTK Biotech and TECHLAB.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Rapid diagnostic tests for gastrointestinal diseases are developed and manufactured. | techlab.com | United States | 1989 | Aug 2022 | •••• | |
Lateral flow immunoassay and ELISA kits for clinical diagnostics | ctkbiotech.com | San Diego, United States | 1997 | Aug 2020 | •••• |
Complete acquisition details for SSI Diagnostica
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of SSI Diagnostica
4 dated milestones of SSI Diagnostica across 6 years, from founding to its latest funding, stage changes and deals.
- Founded SSI Diagnostica is founded.
- Exit Acquired by Adelis Equity Partners.
- Acquisition Acquires CTK Biotech.
- Acquisition Acquires TECHLAB.
Web traffic of SSI Diagnostica
The website of SSI Diagnostica (ssidiagnostica.com) receives about 3.1K visits a month and ranks #3,699,299 among all websites worldwide, #4,746 in Biotechnology and Pharmaceuticals.
- Monthly visits3.1K
▼ 37.9% vs previous month
- Unique visitors2.1K
per month
- Global rank#3,699,299
among all websites
- Category rank#4,746
Health · Biotechnology and Pharmaceuticals
- Bounce rate40%
- Pages per visit1.8
- Average visit29 sec
- DevicesDesktop 37% · Mobile 63%
Websites whose visitors overlap most with SSI Diagnostica. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
revmedconnect.com | revmedconnect.com | 100% | #771,336 | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about SSI Diagnostica
SSI Diagnostica was founded in 2016.
SSI Diagnostica is headquartered in Hillerød, Denmark. It is registered at Hillerød, Capital Region, Denmark.
Soren Skjold Mogensen is the CEO of SSI Diagnostica, as recorded in our data.
Annual revenue of SSI Diagnostica is $44.77M as on Dec 31, 2022.
SSI Diagnostica was founded in 2016 and is based in Hillerod, Denmark. Operations focus on the production of diagnostic kits and quality control testing solutions within the healthcare sector. These products support laboratory and clinical testing needs. The company is led by CEO Soren Skjold Mogensen, with activities centered on European markets.
SSI Diagnostica has made 2 acquisitions, including CTK Biotech, and TECHLAB.
SSI Diagnostica has 1 investor. Key investors include Adelis Equity.
Yes. SSI Diagnostica was acquired by Adelis Equity Partners in March 2016.
